Blocking only the bad side of IL-6 in inflammation and cancer
Author:
Publisher
Elsevier BV
Subject
Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy
Reference128 articles.
1. Targeting immune cell circuits and trafficking in inflammatory bowel disease;Neurath;Nat. Immunol.,2019
2. Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases;Schwartz;Nat. Rev. Rheumatol.,2016
3. Cytokines as therapeutic drugs;Schooltink;J. Interferon Cytokine Res.,2002
4. Development of anti-TNF therapy for rheumatoid arthritis;Feldmann;Nat. Rev. Immunol.,2002
5. 25 years of anti-TNF treatment for inflammatory bowel disease: lessons from the past and a look to the future;D'Haens;Gut,2021
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advancements in the study of IL-6 and its receptors in the pathogenesis of gout;Cytokine;2024-10
2. Network pharmacology study and in vitro experimental validation of Xiaojianzhong decoction against gastric cancer;World Journal of Gastrointestinal Oncology;2024-09-15
3. PPAR-γ/NF-kB/AQP3 axis in M2 macrophage orchestrates lung adenocarcinoma progression by upregulating IL-6;Cell Death & Disease;2024-07-26
4. Inflammation accelerating intestinal fibrosis: from mechanism to clinic;European Journal of Medical Research;2024-06-18
5. The disruptive role of LRG1 on the vasculature and perivascular microenvironment;Frontiers in Cardiovascular Medicine;2024-04-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3